Closed Solicitation · DEPARTMENT OF VETERANS AFFAIRS
AI Summary
The Department of Veterans Affairs is seeking information on non-invasive urine testing for prostate cancer. This sources sought notice aims to identify potential vendors capable of providing a molecular liquid biopsy test that differentiates risk levels for aggressive prostate cancer. Responses are due by April 13, 2026.
REQUEST FOR INFORMATION / SOURCES SOUGHT SYNOPSIS The Department of Veterans Affairs Network Contracting Office (NCO) 19, Rocky Mountain Acquisition Center (RMAC) is issuing this source sought notice as a means of conducting market research to identify parties having an interest in providing Non-Invasive Urine Testing for Prostate Cancer. The result of this market research will contribute to determining the method of procurement to support the following VISN 19 Facilities: Rocky Mountain Regional VA Medical Center (RMRVAMC), 1700 N. Wheeling St, Aurora, CO 80045 Fort Harrison VA Medical Center (FHVAMC), 3687 Veterans Drive, Fort Harrison, MT 59636 Grand Junction VA Medical Center (GJVAMC), 2121 North Ave., Grand Junction, CO 81501 Oklahoma City VA Medical Center (OKCVAMC), 921 NE 13th St., Oklahoma City, OK 73104 Salt Lake City VA Medical Center (SLCVAMC), 500 S. Foothill Dr., Salt Lake City, UT 84148 Muskogee VA Medical Center (MVAMC), 1011 Honor Heights Drive, Muskogee, OK 74401 Ernest Childers VA Outpatient Clinic (ECVC) 8921 S Mingo Rd, Tulsa, OK 74133 The purpose of this RFI is to gather information that will assist in determining the appropriate acquisition strategy for this requirement. This notice does not constitute a solicitation and does not commit the Government to contract for any supply or service. Contractor shall provide a non-invasive urine based molecular liquid biopsy test for men such that the test provides a risk score that helps to differentiate patients with high from a low risk of aggressive prostate cancer and thus indicate the need for a prostate biopsy. The test risk score should be based on an analysis of RNA markers and should not incorporate PSA levels in its algorithm, nor require the DRE (digital rectal exam) prior to collection of the urine specimen. The vendor shall ship test kits directly to patients with a prepaid return label to the vendor s testing facility, and, when requested by the station, provide test kits to the laboratory department for distribution to designated patients with a prepaid return label to the vendor s testing facility. The applicable North American Industry Classification System (NAICS) code assigned to this procurement is 621511 (Medical Laboratories). This is a request for information and sources only, which may or may not lead to a future solicitation! This is not a solicitation. This request for capability information does not constitute a request for proposals; submission of any information in response to this market survey is purely voluntary; the government assumes no financial responsibility for any costs incurred. IN RESPONSE TO THIS ANNOUNCEMENT, PLEASE PROVIDE THE INFORMATION BELOW. IF THIS INFORMATION IS NOT PROVIDED, THEN IT WILL BE ASSUMED THE ENTIRE REQUIREMENT CANNOT BE MET AND YOUR QUOTE WILL NOT BE INCLUDED AS A POTENTIAL SOURCE. NAICS Code: 621511 Company Name: Address: UEI (Unique Entity ID) Number: Contact Name: Phone No.: Email: Business Size Information - Select all that applies: Small Business Emerging Small Business Small Disadvantaged Business Certified under Section 8(a) of the Small Business Act HUBZone Woman Owned Certified Service-Disabled Veteran Owned Small Veteran Owned Small Business Large Business FSS/GSA Contract Holder: Yes No FSS/GSA Contract Number: Effective Date/ Expiration Date: Proposed solution is listed and available on the above FSS/GSA Contract: Yes No Available pricing structure of proposed solution (select all that are applicable below): Pricing Model Please Indicate Availability Below: (Yes / No / NA) All on FSS Open Market only Mix of FSS & Open Market (CPRR) Cost Per Reportable Result Cost Per Test(CPT) Fixed Monthly Charge Other: (Please explain) Federal Acquisition Regulation (FAR) Market Rearch Questions: Questions for Small Businesses ONLY: Limitations on Subcontracting (FAR 52.219-14) What percentage of the work would be subcontracted to another company? ________ If > 0, what is company s business size: __________ If subcontracting, what added value do you offer (FAR 52.215-23): _______________________________ BASED ON THE RESPONSES TO THIS SOURCES SOUGHT NOTICE, THIS REQUIREMENT MAY BE SET-ASIDE FOR SMALL BUSINESSES OR PROCURED THROUGH FULL AND OPEN COMPETITION, and only one award WILL be made. Telephone inquiries will not be accepted or acknowledged, and no feedback or evaluations will be provided to companies regarding their submissions. SUBMISSION INSTRUCTIONS: If your organization can provide these services and is interested in this opportunity, please respond to Alejandra Sierra, Contracting Specialist, via e-mail at Alejandra.Sierra@va.gov and NCO19Lab@va.gov with a statement describing your capabilities and the completed table above. The deadline for responses is Monday, April 13, 2026 at 08:00 AM Mountain time.
Q301--PROSTATE TESTING NON-INVASIVE | VISN 19 is a federal acquisition solicitation issued by DEPARTMENT OF VETERANS AFFAIRS. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.